Recognizing innovative strength
In many companies, IP rights are simply not on the agenda – and if they are, they’re often a matter for management. How is it at your company? No doubt a great deal of innovative potential lies in your company too. Just think of your employees and the ideas they sometimes come up with to trigger new developments!
UPC Update - The new CMS is online
On July 8, the UPC has launched the first phase of its new CMS-rollout. Starting with limited functional scope, the new CMS is set to become fully operational in September.
G 1/23: No “Enablement” Hurdle for Prior Art Products Put on the Market – EPO Clarifies Scope of Prior Art
Enlarged Board of Appeal confirms: Commercially available products are prior art, even if they are not fully analyzable or reproducible
How the EPO addresses public prior use in clinical trials and patentability obstacles for pharmaceutical inventions
This article explores how the European Patent Office (EPO) addresses public prior use in the context of clinical trials.
IP strategies for the second funding round
As you scale, investors are looking at more than the potential of your IP, says Mathias Karlhuber. They now want to know whether it can support future growth and withstand any attacks.